| # | Drug | Count |
|---|---|---|
| 0 | FINGOLIMOD HCL | 13 |
| 1 | FOLIC ACID | 12 |
| 2 | ALPRAZOLAM | 10 |
| 3 | CETIRIZINE HYDROCHLORIDE | 10 |
| 4 | OMEPRAZOLE MAGNESIUM | 10 |
| 5 | ANTACID | 9 |
| 6 | CALCIUM CARBONATE | 9 |
| 7 | CETIIRIZINE | 9 |
| 8 | CETIRIZINE | 9 |
| 9 | CISPLATIN | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SELUMETINIB | 9 | 0.0053 |
| 1 | PROPYLTHIOURACIL | 7 | 0.0034 |
| 2 | FLECAINIDE ACETATE | 8 | 0.0015 |
| 3 | NELFINAVIR MESYLATE | 2 | 0.0010 |
| 4 | TRIMETHOBENZAMIDE HYDROCHLORIDE | 1 | 0.0007 |
| 5 | PEGFILGRASTIM | 8 | 0.0007 |
| 6 | NOREPINEPHRINE BITARTRATE | 8 | 0.0005 |
| 7 | IFOSFAMIDE FOR INJECTION | 8 | 0.0004 |
| 8 | OXAZEPAM | 8 | 0.0004 |
| 9 | PROGESTERONE | 8 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vitamin B12 [EPC] | 13 |
| 1 | Benzodiazepine [EPC] | 12 |
| 2 | Vitamin C [EPC] | 12 |
| 3 | Vitamin D [EPC] | 12 |
| 4 | Kinase Inhibitor [EPC] | 10 |
| 5 | Proton Pump Inhibitor [EPC] | 10 |
| 6 | Alkylating Drug [EPC] | 9 |
| 7 | Cardiac Glycoside [EPC] | 9 |
| 8 | Histamine-1 Receptor Antagonist [EPC] | 9 |
| 9 | Platinum-based Drug [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thyroid Hormone Synthesis Inhibitor [EPC] | 7 | 0.0007 |
| 1 | Progesterone [EPC] | 8 | 0.0003 |
| 2 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 3 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 2 | 0.0002 |
| 4 | Bismuth [EPC] | 1 | 0.0002 |
| 5 | Cardiac Glycoside [EPC] | 9 | 0.0001 |
| 6 | Histamine-1 Receptor Antagonist [EPC] | 9 | 0.0001 |
| 7 | Topoisomerase Inhibitor [EPC] | 8 | 0.0001 |
| 8 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 9 | Catecholamine [EPC] | 6 | 0.0001 |